{"id":"https://openalex.org/W4403520175","doi":"https://doi.org/10.1158/2326-6074.tumimm24-b002","title":"Abstract B002: HIF-2A inhibition in adaptive immunity against cancer growth","display_name":"Abstract B002: HIF-2A inhibition in adaptive immunity against cancer growth","publication_year":2024,"publication_date":"2024-10-18","ids":{"openalex":"https://openalex.org/W4403520175","doi":"https://doi.org/10.1158/2326-6074.tumimm24-b002"},"language":"en","primary_location":{"id":"doi:10.1158/2326-6074.tumimm24-b002","doi":"https://doi.org/10.1158/2326-6074.tumimm24-b002","is_oa":false,"landing_page_url":"https://doi.org/10.1158/2326-6074.tumimm24-b002","pdf_url":null,"source":{"id":"https://openalex.org/S2765010658","display_name":"Cancer Immunology Research","issn_l":"2326-6066","issn":["2326-6066","2326-6074"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005538074","display_name":"Katya Frazier","orcid":"https://orcid.org/0000-0003-3728-6738","observed_orcids":["https://orcid.org/0000-0003-3728-6738"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katya Frazier","raw_affiliation_strings":["Merck & Co., Inc., Boston, MA, 1"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Boston, MA, 1","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026798889","display_name":"Eric S. Muise","orcid":"https://orcid.org/0000-0002-1238-5118","observed_orcids":["https://orcid.org/0000-0002-1238-5118"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Muise","raw_affiliation_strings":["Merck & Co., Inc., Boston, MA, 1"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Boston, MA, 1","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Joshua Stolz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joshua Stolz","raw_affiliation_strings":["Merck & Co., Inc., Boston, MA, 1"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Boston, MA, 1","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Lukas Fischer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lukas Fischer","raw_affiliation_strings":["Merck & Co., Inc., Boston, MA, 1"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Boston, MA, 1","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102968507","display_name":"Mark Buchanan","orcid":"https://orcid.org/0009-0005-8555-273X","observed_orcids":["https://orcid.org/0009-0005-8555-273X"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark Buchanan","raw_affiliation_strings":["Merck & Co., Inc., Boston, MA, 1"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Boston, MA, 1","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Charlie Schneider","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charlie Schneider","raw_affiliation_strings":["Merck & Co., Inc., Cambridge, MA, 2"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Cambridge, MA, 2","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Brian Pak Ho Chan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Pak Ho Chan","raw_affiliation_strings":["Merck & Co., Inc., Cambridge, MA, 2"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Cambridge, MA, 2","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Richard Carr","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard Carr","raw_affiliation_strings":["Merck & Co., Inc., West Point, PA. 3"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., West Point, PA. 3","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068785092","display_name":"Rodolfo F. Perini","orcid":"https://orcid.org/0009-0002-4400-5260","observed_orcids":["https://orcid.org/0009-0002-4400-5260"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rodolfo Perini","raw_affiliation_strings":["Merck & Co., Inc., Boston, MA, 1"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Boston, MA, 1","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041237312","display_name":"Brian J. Long","orcid":"https://orcid.org/0000-0002-8202-8589","observed_orcids":["https://orcid.org/0000-0002-8202-8589"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Long","raw_affiliation_strings":["Merck & Co., Inc., Boston, MA, 1"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Boston, MA, 1","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048640117","display_name":"Douglas E. Linn","orcid":"https://orcid.org/0009-0000-4500-5284","observed_orcids":["https://orcid.org/0009-0000-4500-5284"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Douglas Linn","raw_affiliation_strings":["Merck & Co., Inc., Boston, MA, 1"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Boston, MA, 1","institution_ids":["https://openalex.org/I1285764155"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1285764155"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"12","issue":"10_Supplement","first_page":"B002","last_page":"B002"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8485999703407288,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8485999703407288,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.125,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0034000000450760126,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/belzutifan","display_name":"belzutifan","score":0.9779999852180481},{"id":"https://openalex.org/keywords/renal-cell-carcinoma","display_name":"renal cell carcinoma","score":0.7919999957084656},{"id":"https://openalex.org/keywords/adaptive-immunity","display_name":"adaptive immunity","score":0.7770000100135803},{"id":"https://openalex.org/keywords/t-cell-activation","display_name":"T cell activation","score":0.7950000166893005},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.9539999961853027},{"id":"https://openalex.org/keywords/anti-pd-1-antibody","display_name":"anti-PD-1","score":0.9589999914169312},{"id":"https://openalex.org/keywords/anti-ctla-4","display_name":"anti-CTLA-4","score":0.9990000128746033},{"id":"https://openalex.org/keywords/tumor-hypoxia","display_name":"tumor hypoxia","score":0.7590000033378601},{"id":"https://openalex.org/keywords/t-cell-infiltration","display_name":"T cell infiltration","score":0.6539999842643738},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.7099999785423279},{"id":"https://openalex.org/keywords/tumor-regression","display_name":"tumor regression","score":0.6129999756813049},{"id":"https://openalex.org/keywords/humanized-mouse-model","display_name":"humanized mice","score":0.8519999980926514}],"concepts":[{"id":"https://openalex.org/C2779341262","wikidata":"https://www.wikidata.org/wiki/Q182581","display_name":"Immunity","level":3,"score":0.5917292237281799},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.5348305702209473},{"id":"https://openalex.org/C193419808","wikidata":"https://www.wikidata.org/wiki/Q1645075","display_name":"Acquired immune system","level":3,"score":0.5159264802932739},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4798676371574402},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.43188461661338806},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4162297248840332},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4025769829750061},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.3759431838989258},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.3605141341686249},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.35002511739730835},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1800820231437683}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/2326-6074.tumimm24-b002","doi":"https://doi.org/10.1158/2326-6074.tumimm24-b002","is_oa":false,"landing_page_url":"https://doi.org/10.1158/2326-6074.tumimm24-b002","pdf_url":null,"source":{"id":"https://openalex.org/S2765010658","display_name":"Cancer Immunology Research","issn_l":"2326-6066","issn":["2326-6066","2326-6074"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2486559672","https://openalex.org/W3111580887","https://openalex.org/W3185708072","https://openalex.org/W2986423947","https://openalex.org/W2496337048","https://openalex.org/W3049036915","https://openalex.org/W4386773231","https://openalex.org/W3132807398","https://openalex.org/W2893846263","https://openalex.org/W2561535599"],"abstract_inverted_index":{"Abstract":[0],"Hypoxia":[1],"Inducible":[2],"Factors":[3],"(HIFs)":[4],"are":[5,56,84],"transcription":[6],"factors":[7],"implicated":[8],"in":[9,30,61,87,167,186,199,206,227,292,295,327,341],"many":[10],"cellular":[11],"processes":[12],"key":[13],"to":[14,74,196,235,284],"survival,":[15],"proliferation,":[16],"and":[17,38,50,54,70,121,144,223,274,281,294,346],"function,":[18,124],"particularly":[19],"for":[20,48,94,279],"cancer":[21,331],"cells.":[22,264],"HIF2A":[23,43,55,182,228],"has":[24],"been":[25,72],"identified":[26],"as":[27],"an":[28,200],"oncogene":[29],"the":[31,62,98,107,115,236,254,286,337],"context":[32],"of":[33,138,150,181,213,218,241,247,261,272,336],"renal":[34],"cell":[35,77,123,153,171,221,249],"carcinoma":[36],"(RCC),":[37],"belzutifan":[39,273],"(MK-6482)":[40],"is":[41,46],"a":[42,216,224],"inhibitor":[44],"that":[45,101,160,253],"FDA-approved":[47],"VHL-associated":[49],"advanced":[51,95],"RCC.":[52],"HIF1A":[53],"expressed":[57],"by":[58,130,142,155,290],"all":[59],"cells":[60,140],"hypoxic":[63],"tumor":[64,209,237],"microenvironment,":[65],"including":[66],"anti-tumor":[67,136,259],"immune":[68,90,109,146,176,189],"cells,":[69],"have":[71,105],"shown":[73],"drive":[75],"T":[76,122,139,152,220,248,263],"effector":[78],"function.":[79],"Several":[80],"ongoing":[81],"clinical":[82,270],"trials":[83],"evaluating":[85],"MK-6482":[86,102,131,161,185],"combination":[88,187,255,277],"with":[89,173,188],"checkpoint":[91,147,177,190,275],"blockade":[92,191,276],"therapy":[93],"RCC,":[96,280],"however":[97],"potential":[99,287],"impact":[100,133],"may":[103],"directly":[104],"on":[106],"adaptive":[108,328],"response":[110],"remains":[111],"poorly":[112],"understood.":[113],"Considering":[114],"functional":[116],"link":[117],"between":[118],"HIF":[119],"signaling":[120],"we":[125,282],"explored":[126],"whether":[127],"HIF-2A":[128,325],"inhibition":[129,326],"could":[132],"activation":[134,154,250],"and/or":[135],"action":[137],"supported":[141],"anti-PD-1":[143],"anti-CTLA-4":[145],"blockade.":[148],"Interrogation":[149],"primary":[151],"mixed":[156],"lymphocyte":[157],"reaction":[158],"revealed":[159,215,244],"did":[162],"not":[163],"induce":[164],"significant":[165,225],"changes":[166],"cytokine":[168],"secretion":[169],"or":[170,174],"proliferation":[172],"without":[175],"blockade,":[178],"despite":[179],"evidence":[180],"protein":[183,229],"reduction.":[184],"increased":[192,219,245],"antitumor":[193],"efficacy":[194],"compared":[195],"either":[197],"alone":[198],"RCC":[201],"humanized":[202],"mouse":[203],"model,":[204],"resulting":[205],"almost":[207],"complete":[208],"regression.":[210,238],"IHC":[211],"analysis":[212],"tumors":[214,242],"trend":[217],"infiltration":[222],"reduction":[226],"following":[230],"combined":[231],"treatment,":[232],"potentially":[233],"contributing":[234],"mRNA":[239],"sequencing":[240],"also":[243],"expression":[246],"pathways,":[251],"suggesting":[252],"treatment":[256,278],"induced":[257],"greater":[258],"activity":[260],"infiltrating":[262],"Together,":[265],"our":[266],"data":[267],"support":[268],"continued":[269],"evaluation":[271],"continue":[283],"explore":[285],"mechanistic":[288],"effects":[289],"both":[291],"vivo":[293],"vitro":[296],"follow-up":[297],"studies.":[298],"Citation":[299],"Format:":[300],"Katya":[301],"Frazier,":[302],"Eric":[303],"Muise,":[304],"Joshua":[305],"Stolz,":[306],"Lukas":[307],"Fischer,":[308],"Mark":[309],"Buchanan,":[310],"Charlie":[311],"Schneider,":[312],"Brian":[313,321],"Pak":[314],"Ho":[315],"Chan,":[316],"Richard":[317],"Carr,":[318],"Rodolfo":[319],"Perini,":[320],"Long,":[322],"Douglas":[323],"Linn.":[324],"immunity":[329],"against":[330],"growth":[332],"[abstract].":[333],"In:":[334],"Proceedings":[335],"AACR":[338],"Special":[339],"Conference":[340],"Cancer":[342,356],"Research:":[343],"Tumor":[344],"Immunology":[345],"Immunotherapy;":[347],"2024":[348],"Oct":[349],"18-21;":[350],"Boston,":[351],"MA.":[352],"Philadelphia":[353],"(PA):":[354],"AACR;":[355],"Immunol":[357],"Res":[358],"2024;12(10":[359],"Suppl):Abstract":[360],"nr":[361],"B002.":[362]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2025-10-10T00:00:00"}